Skip to main content
. Author manuscript; available in PMC: 2014 Aug 11.
Published in final edited form as: Angiogenesis. 2013 Jul 23;16(4):953–962. doi: 10.1007/s10456-013-9368-3

Figure 5. Interferon α-2b-Mediated Decreases in the ratio of pCHSPC:nCHSPC in Transplanted Mice with C32 Melanoma Xenografts.

Figure 5

NOD/SCID/γchainnull mice were first transplanted with human CD34+ cells and then the C32 melanoma was implanted on the flank 4 weeks post-transplantation. Following two weeks of C32 melanoma unrestricted growth, some mice were treated with Interferon α-2b (Intron-A; 50,000U × 3 times per week) and tumor volume was measured via caliper over time (a). There were decreased pCHSPCs in the peripheral blood following Interferon α-2b treatment (b).